Abstract:The ability of cholesterol esterase to catalyze the synthesis of cholesterol esters has been considered to be of limited physiological significance because of its bile salt requirements for activity, though detailed kinetic studies have not been reported. This study was performed to determine the taurocholate, pH, and substrate requirements for optimal cholesterol ester synthesis catalyzed by various pancreatic lipolytic enzymes, including the bovine 67- and 72-kDa cholesterol esterases, human 100-kDa cholesterol esterase, and human 52-kDa triglyceride lipase. In contrast to current beliefs, cholesterol esterase exhibits a bile salt independent as well as a bile salt dependent synthetic pathway. For the bovine pancreatic 67- and 72-kDa cholesterol esterases, the bile salt independent pathway is optimal at pH 6.0-6.5 and is stimulated by micromolar concentrations of taurocholate. For the bile salt dependent synthetic reaction for the 67-kDa enzyme, increasing the taurocholate concentration from 0 to 1.0 mM results in a progressive shift in the pH optimum from pH 6.0-6.5 to pH 4.5 or lower. In contrast, cholesterol ester hydrolysis by the 67-, 72-, and 100-kDa enzymes was characterized by pH optima from 5.5 to 6.5 at all taurocholate concentrations. Optimum hydrolytic activity for these three enzyme forms occurred with 10 mM taurocholate. Since hydrolysis is minimal at low taurocholate concentrations, the rate of synthesis actually exceeds hydrolysis when the taurocholate concentration is less than 1.0 mM. The 52-kDa enzyme exhibits very low cholesterol ester synthetic and hydrolytic activities, and for this enzyme both activities are bile salt independent. Thus, our data show that cholesterol esterase has both bile salt independent and bile salt dependent cholesterol ester synthetic activities and that it may catalyze the net synthesis of cholesterol esters under physiological conditions.

Joint Modeling of Survival and Backwards Recurrence Outcomes: an Analysis of Factors Associated with Fertility Treatment

Joint Modeling of Geometric Features of Longitudinal Process and Discrete Survival Time Measured on Nested Timescales: An Application to Fecundity Studies

Assessing the distribution of discrete survival time in presence of recall error

Exogenous time-varying covariates in double additive cure survival model with application to fertility

Accounting for informative observation process in transition models of binary longitudinal outcome: Application to medical record data

A joint analysis proposal of nonlinear longitudinal and time-to-event right-, interval-censored data for modeling pregnancy miscarriage

Joint modeling of zero-inflated longitudinal measurements and time-to-event outcomes with applications to dynamic prediction

Joint analysis of longitudinal measurements and survival times with a cure fraction based on partly linear mixed and semiparametric cure models

Incorporating delayed entry into the joint frailty model for recurrent events and a terminal event

Accelerated failure time models for recurrent event data analysis and joint modeling

Shared parameter models for joint analysis of longitudinal and survival data with left truncation due to delayed entry – Applications to cystic fibrosis

Joint models with multiple longitudinal outcomes and a time-to-event outcome: a corrected two-stage approach

A joint model for (un)bounded longitudinal markers, competing risks, and recurrent events using patient registry data

Modelling fertility potential in survivors of childhood cancer: An introduction to modern statistical and computational methods

Relation between three classes of structural models for the effect of a time-varying exposure on survival

Pancreatic cholesterol esterases. 3. Kinetic characterization of cholesterol ester resynthesis by the pancreatic cholesterol esterases.

MODELLING COUNTY LEVEL BREAST CANCER SURVIVAL DATA USING A COVARIATE-ADJUSTED FRAILTY PROPORTIONAL HAZARDS MODEL

Targeted Estimation of Heterogeneous Treatment Effect in Observational Survival Analysis

Patterns and predictors of follow-up in patients with mild traumatic brain injury

Joint Modeling of Longitudinal and Survival Data with Censored Single-index Varying Coefficient Models

Surrogacy Validation for Time-to-Event Outcomes with Illness-Death Frailty Models